Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells

Author:

Hong WeiqiORCID,Yang Jingyun,Zou Jun,Bi Zhenfei,He Cai,Lei Hong,He Xuemei,Li Xue,Alu Aqu,Ren Wenyan,Wang Zeng,Jiang Xiaohua,Zhong Kunhong,Jia Guowen,Yang Yun,Yu Wenhai,Huang Qing,Yang Mengli,Zhou Yanan,Zhao Yuan,Kuang Dexuan,Wang Junbin,Wang Haixuan,Chen Siyuan,Luo MinORCID,Zhang Ziqi,Lu Tianqi,Chen Li,Que Haiying,He Zhiyao,Sun Qiu,Wang Wei,Shen Guobo,Lu Guangwen,Zhao Zhiwei,Yang Li,Yang Jinliang,Wang Zhenling,Li Jiong,Song Xiangrong,Dai LunzhiORCID,Chen Chong,Geng Jia,Gou Maling,Chen Lu,Dong HaohaoORCID,Peng Yong,Huang CanhuaORCID,Qian Zhiyong,Cheng Wei,Fan Changfa,Wei Yuquan,Su Zhaoming,Tong Aiping,Lu ShuaiyaoORCID,Peng Xiaozhong,Wei XiaweiORCID

Abstract

AbstractNeutrophil extracellular traps (NETs) can capture and kill viruses, such as influenza viruses, human immunodeficiency virus (HIV), and respiratory syncytial virus (RSV), thus contributing to host defense. Contrary to our expectation, we show here that the histones released by NETosis enhance the infectivity of SARS-CoV-2, as found by using live SARS-CoV-2 and two pseudovirus systems as well as a mouse model. The histone H3 or H4 selectively binds to subunit 2 of the spike (S) protein, as shown by a biochemical binding assay, surface plasmon resonance and binding energy calculation as well as the construction of a mutant S protein by replacing four acidic amino acids. Sialic acid on the host cell surface is the key molecule to which histones bridge subunit 2 of the S protein. Moreover, histones enhance cell–cell fusion. Finally, treatment with an inhibitor of NETosis, histone H3 or H4, or sialic acid notably affected the levels of sgRNA copies and the number of apoptotic cells in a mouse model. These findings suggest that SARS-CoV-2 could hijack histones from neutrophil NETosis to promote its host cell attachment and entry process and may be important in exploring pathogenesis and possible strategies to develop new effective therapies for COVID-19.

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3